UK Cancer clinical trials to be streamlined

Set up and delivery of UK cancer multi-center clinical trials will become more efficient and easier to get off the ground, thanks to a new agreement between UK cancer clinical trial centers.
The Experimental Cancer Medicines Center (ECMC) Collaboration Agreement will improve the network’s ability to carry out early phase clinical cancer trials, boosting research and development in the UK and bringing innovative new treatments to patients sooner.
Clinical trials in the UK often face delays because of the variation in how they are set up in each center. But under the new agreement all 18 ECMC locations will do this in the same way and will work to the same standards, cutting paperwork and helping researchers work more collaboratively.
This will help speed up approval of early phase clinical trials, making the UK a more attractive location for international pharmaceutical and life sciences companies. This means UK patients get access to innovative treatments sooner.